fbpx
Medical Innovation Exchange

Vertex absorbs ViaCyte and its stem cell-based diabetes treatment for $320M, clearing out competition

https://www.fiercebiotech.com/biotech/vertex-absorbs-viacyte-320m-clearing-out-competition-stem-cell-based-diabetes-treatments

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.